Make an Impact During National...

Show your support for those living with eosinophil-associated diseases by joining APFED’s celebration of the...

APFED Launches EoE Awareness Campaign...

New series of digital advertisements will educate visitors about eosinophilic esophagitis (EoE) and its symptoms...

APFED Announces 2023 AAAAI/APFED Best...

Two recipients are recognized for best-scoring abstracts focused on eosinophilic gastrointestinal diseases (EGIDs) ATLANTA, GA...

APFED’s Executive Director Recognized with...

Strobel received the award during the Annual Meeting of the American Academy of Allergy, Asthma...

2022 Annual Meeting of the...

APFED was onsite at the American College of Gastroenterology’s (ACG) Annual Scientific Meeting and Postgraduate...

APFED Announces Fei Li Kuang...

(Atlanta, GA)— The American Partnership for Eosinophilic Disorders (APFED) is proud to announce that, thanks...

APFED Announces 2022 NASPGHAN Outstanding...

Award honors two best-scoring abstracts focused on eosinophilic gastrointestinal disease (Atlanta, GA)—The American Partnership for...

Voice of the Patient Report:...

“Asthma has truly impacted, not just my life and the way I live every day,...

Deadline July 15: Call to...

Call to action! This is our best year to pass the Medical Nutrition Equity Act!...

APFED Announces Recipient for 2022...

APFED is proud to announce that, thanks to the generosity of our donors, we are...

APFED to Host Patient Education...

EOS Connection 2022 will offer the latest research developments, practical management strategies, and opportunities for...

2022 Annual Meetings: ATS and...

American Thoracic Society and Digestive Disease Week® 2022 APFED attended two large medical conferences in...

New Discounted Registration for EOS...

We understand the challenges of today’s economy and the rising costs of travel. APFED is...

Updates on Formula Shortage

Page updated 7/13/22 Background In February 2022, the U.S. Food and Drug Administration (FDA) announced...

Dupixent® Receives FDA Approval to...

Dupixent® Receives FDA Approval to Treat EoE in People Ages 12 and Older Injection is...

National Eosinophil Awareness Week (May...

Atlanta, GA (May 13, 2022) – The American Partnership for Eosinophilic Disorders (APFED) will celebrate...

How You Can Make an...

Mark your calendars for National Eosinophil Awareness Week, May 15-21, 2022! The third week of...

American Partnership for Eosinophilic Disorders...

(Atlanta, GA) --The Board of Directors of the American Partnership for Eosinophilic Disorders (APFED) has...

2022 Annual Meeting of AAAAI

AAAAI represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special...

International Consensus Recommendations EGID Nomenclature

International consensus surrounding what subsets of eosinophilic gastrointestinal diseases (EGIDs) should now be called for...

Response to FDA denial of...

In December 2021, APFED reported that the U.S. Food and Drug Administration (FDA) denied the...

Action Needed on Medical Nutrition...

The Medical Nutrition Equity Act (MNEA, S2013/HR3783) would provide consistent, nationwide insurance coverage of medically necessary foods,...

Industry News: Drug Development

  FDA denies approval of TAK-721 (budesonide oral suspension) for EoE Takeda, the pharmaceutical company...

APFED is Accepting Applications for...

The 2022 APFED HOPE Pilot Grant has been established to foster the development of new...

EGID Research at 2021 ACG...

The annual scientific meeting of the American College of Gastroenterology (ACG) was held Oct. 22-27,...

New Initiative Brings Voice of...

FOR IMMEDIATE RELEASE Four nonprofit organizations collaborate to bring “Little Airways, Big Voices” to the...

APFED Debuts New Podcast Series

“Real Talk: Eosinophilic Diseases” will feature free podcast conversations about living with eosinophil-associated diseases (Atlanta,...

APFED Announces Recipient for 2021...

New research project will investigate the role of detergents in the pathogenesis of Eosinophilic Esophagitis...

Panelists Needed to Share Perspectives...

APFED is partnering with the Allergy & Asthma Network, the American Lung Association, and the...

APFED to Host Virtual Patient...

EOS Connection 2021 will feature the latest research developments, practical management strategies, and opportunities for...

Medical Foods Advocates Needed

We invite community members to join us in advocating for the Medical Nutrition Equity Act....

National Eosinophil Awareness Week (May...

The American Partnership for Eosinophilic Disorders (APFED) will celebrate the 14th annual National Eosinophil Awareness...

5 Ways to Make an...

Show your support for those who live with eosinophil-associated diseases and educate others about these...

Update on EoE Research Co-Funded...

Important new research that may help identify the foods that cause eosinophilic esophagitis (EoE) was...

New Resource for Eosinophilic Asthma

Eosinophilic asthma is a subtype of asthma that is difficult to control with traditional asthma...

APFED Announces 2020 HOPE Pilot...

Funded study will examine the role of QSOX1 in the pathogenesis of eosinophil-related diseases ATLANTA,...

Lirentelimab Shows Promise as a...

In a publication in the October 22, 2020 issue of New England Journal of Medicine,...

Research Updates from ACG 2020...

The annual scientific meeting of the American College of Gastroenterology took place online, Oct. 23-28,...

APFED’s Virtual Hike for HOPE...

For Immediate Release APFED Contact: Mary Jo Strobel, Executive Director, (713) 493-7749, mjstrobel@apfed.org APFED’s Virtual...

APFED and IES Announce Establishment...

For Immediate Release APFED Contact: Mary Jo Strobel, Executive Director, (713) 493-7749, mjstrobel@apfed.org IES Contact:...

APFED Will Host Virtual Patient...

EOS Connection 2020 offers the latest in science and research on eosinophil-associated diseases, practical management...

A Statement from APFED

We are deeply saddened by recent events in America. APFED stands united and unwavering against...

APFED & CEGIR Announce Recipient...

ATLANTA, GA & CINCINNATI, OH – APFED and CEGIR have awarded a 2020 co-funded pilot...

Meet Kaylee!

Last September, not long before her 8th birthday, Kaylee was diagnosed with eosinophilic fasciitis, a...

APFED Announces Recipient for 2020...

Funded study seeks to define the molecular and immunologic details of t-cell antigen specificity in...

6 Easy Ways You Can...

Looking for simple ways to make an impact during National Eosinophil Awareness Week? Learn how...

National Eosinophil Awareness Week (May...

Community rallies for action and awareness of chronic, inflammatory conditions (Atlanta, GA)—The American Partnership for...

May 5th Is #GivingTuesdayNow!

On May 5, in a show of global solidarity and philanthropy, people will be participating...

COVID-19 Potential Impact on Eosinophil-Associated...

The American Partnership for Eosinophilic Disorders (APFED) is closely monitoring developments regarding the novel coronavirus...

New App for Eos Connection...

Eos Connection Online Support Community: There’s an App for That! Learn and Connect with Others...

Share Your EGPA Perspectives

APFED is working in partnership with a Medscape, the largest provider of continuing medical education...

Rare Disease Day 2020

The rare disease patient community will come together in unity to celebrate Rare Disease Day...

$7 Million Match for #GivingTuesday...

This year, in support of #GivingTuesday on December 3, 2019, Facebook is matching up to...

Highlights from the 2019 NORD...

APFED was honored to receive a scholarship to attend the 2019 NORD Rare Diseases and...

Highlights from ACG 2019

This week, APFED was onsite at the American College of Gastroenterology’s 84th Annual Scientific Meeting...

Highlights from the 2019 NASPGHAN/CPNP/APGNN...

The 2019 NASPGHAN/CPNP/APGNN Annual Meeting was held in Chicago Oct 16-19. APFED leadership attended the...

2019 NASPGHAN Outstanding EGID Abstract...

Award recognizes two best-scoring abstracts focused on eosinophilic gastrointestinal disease (Atlanta, GA)— The American Partnership...

Steven Page Trio Headlines NYC...

“Charit-EoE Concert for a Cure for Eosino…what???” will help fund research for eosinophil-associated diseases (Atlanta,...

Consortium of Eosinophilic Gastrointestinal Disease...

For Immediate Release American Partnership for Eosinophilic Disorders P.O. Box 29545 Atlanta, GA 30359 www.apfed.org...

Supporting Students with Eosinophil-Associated Disease...

APFED’s efforts focus on creating a supportive and safe environment for students affected by chronic...

APFED Invites Scientific Community to...

Community Donations to APFED Will Fund New Research of Eosinophil-associated Diseases  (Atlanta, GA)— The American...

Shelly Parks Recognized with 2019...

Each year, APFED’s volunteer Board of Directors honors an APFED member who has shown a...

APFED to Kick Off 17th...

(Atlanta, GA)—The American Partnership for Eosinophilic Disorders (APFED) is pleased to announce that its 17th...

APFED to Host Patient Education...

Contact: Mary Jo Strobel, American Partnership for Eosinophilic Disorders, Phone: (713)-493-7749, Email: mjstrobel@apfed.org PRESS RELEASE For...

Eos Connection 2019: Why Attend?

Join patients and families from across the country at APFED’s 17th Annual Patient Education Conference...

Digestive Disease Week® (DDW)

APFED is onsite this weekend at Digestive Disease Week® (DDW) in San Diego. This event...

National Eosinophil Awareness Week (May...

Eosinophil-associated diseases community bands together for awareness and action  (Atlanta, GA)— During National Eosinophil Awareness...

New CEGIR Site Announced

Contacts: Jennifer Knowles, University of Utah, Phone: (801)-587-9050, E-mail: Jennifer.Knowles@hsc.utah.edu   Mary Jo Strobel, American...

Applications Accepted for APFED Scholarship...

APFED is now accepting applications for the Haley Royko Memorial Scholarship, established in memory of...

Update on New ICD-10-CM Codes...

Over the past year, APFED and the International Eosinophil Society (IES) partnered to propose and...

2019 AAAAI/APFED Best Abstract on...

Award winners recognized for best-scoring abstracts focused on eosinophilic gastrointestinal disease (Atlanta, GA)— The American...

Research Updates

A paper published in the January issue of Annals of Allergy & Immunology describes case...

Call to Action: Medical Nutrition...

The Patients & Providers for Medical Nutrition Equity (PPMNE) coalition, a collaborative effort in which...

EGID Patient Input Needed

New surveys for and research interview opportunities have been posted for patients with eosinophilic gastrointestinal...

New CEGIR Site Announced

Contacts:  Munazza Noor, Baylor College of Medicine, Phone: (832)-824-0939, E-mail: munazza.noor@bcm.edu Mary Jo Strobel, American Partnership...

$7 Million Match for #GivingTuesday...

This year, in support of #GivingTuesday on November 27, 2018, Facebook is partnering with PayPal...

Thanksgiving Recipes for an Elimination...

Food-focused holidays like Thanksgiving can be challenging for those on an elimination diet. Leading up...

#TealPumpkinProject

Over the past four years, households around the globe have participated in the @tealpumpkinproject. APFED...

Mid-Year Progress Report

Thanks to community support, APFED has made great progress in the first half of 2018!...

Back to School with APFED

Back to school time is almost here, and it’s time to pave the way for...

Input Needed From EG, EC...

Researchers are working to bring new therapies to the patients who need them. Patient interviews/surveys...

APFED Honors Michaella Lesieur with...

Every year, APFED’s Executive Board recognizes an APFED member who has shown a deep commitment...

APFED’s 2018 Eos Connection Patient...

(Atlanta, GA)— The American Partnership for Eosinophilic Disorders (APFED) will be hosting its 16th annual...

APFED Announces 2018 Hope APFED...

Funded study will examine the long-term consequences of eosinophil depletion and the immunoregulatory role of...

APFED and IES to Partner...

The American Partnership for Eosinophilic Disorders (APFED, apfed.org) and the International Eosinophil Society (IES, eosinophil-society.org)...

Join APFED in Recognizing National...

Contact: Mary Jo Strobel, Executive Director, (713) 493-7749, mjstrobel@apfed.org Eosinophil-associated disease (EAD) community unites for...

American Partnership for Eosinophilic Disorders...

Contact: Mary Jo Strobel, Executive Director, (713) 493-7749, mjstrobel@apfed.org ATLANTA, GA —The Board of Directors...

Recipient Announced for the 2018...

Funded study to define the consequences and mechanisms of mucosal mast cell activation in the...

Show the LOVE During NEAW...

Join us for APFED’s #EndEos #WithLove campaign on Facebook! It’s east to create a Facebook...

RE-TREAD: Revisiting the NIH Taskforce...

Today, an important review paper was published in the Journal of Leukocyte Biology. The publication,...

2018 Hope APFED/AAAAI Pilot Grant...

Funded study to look at effects of proton pump inhibitor treatment on genes associated with...

2018 AAAAI/APFED Best Abstract on...

Researchers recognized for best-scoring abstracts focusing on eosinophilic gastrointestinal disease ATLANTA, GA — The American...

Save the Date for Eos...

APFED’s 16th Annual Patient Conference on Eosinophilic Gastrointestinal Diseases Hyatt Aurora Denver, CO July 6-7,...

Adam Rantz Memorial Golf Outing

Calling all friends in the Pennsylvania area! Join us on Friday, May 18 for the 2nd...

Together, We Did It!

Thank you for helping us meet — and beat! — the $150,000 HOPE Challenge! It’s...

Breaking News: EGPA Treatment Approved

GlaxoSmithKline has announced that the FDA has approved Nucala (mepolizumab) as the first targeted treatment...

Your Donations at Work

Read how APFED has moved its mission forward this year, thanks to the generous support...

Support APFED While You Shop!

Support APFED when you shop on Black Friday and throughout the year. Go to smile.amazon.com/ch/76-0700153...

Help Us Reach Our Goal!

Join APFED in celebrating its 15th anniversary by participating in our $150,000 HOPE challenge! APFED...

Mike DelGuidice and Big Shot...

Billy Joel tribute band will perform in New York City to fund research for eosinophilic...

Concert for a Cure

Featuring Mike Delguidice and Big Shot, Celebrating the Music of Billy Joel Friday, Nov. 10...

Knopp Biosciences and APFED Announce...

FOR IMMEDIATE RELEASE PITTSBURGH, PA, and ATLANTA, GA, September 6, 2017—Knopp Biosciences LLC and the...

Nutritional Support for Families Impacted...

APFED is working in partnership with many organizations, including Children’s Medical Nutrition Alliance and the International...

APFED Announces 2018 HOPE Pilot...

The American Partnership for Eosinophilic Disorders (APFED) is pleased to announce that two 2018 HOPE...

Medical Nutrition Equity Act of...

This spring, the Medical Nutrition Equity Act was reintroduced into Congress. This legislation would require...

Revised Draft of the Better Care Reconciliation Act of 2017 A revised draft of the...

APFED Awards 2017 Elizabeth Allen...

Each year, APFED’s Executive Board awards an APFED member who has shown great dedication to...

APFED Holds 15th Annual Eos...

(Atlanta, GA)—The American Partnership for Eosinophilic Disorders (APFED) is hosting its 15th Annual Patient Education...

APFED Kicks Off National Eosinophil...

Eosinophil-associated diseases community bands together for awareness and action (ATLANTA, GA)—This week (May 14-20, 2017),...

10 Simple Ways to Support...

May 14-20 is National Eosinophil Awareness Week, and there are plenty of proactive things you...

APFED ANNOUNCES 2017 HOPE RESEARCH...

Funding supports researchers who have novel approaches to understanding eosinophilic esophagitis (ATLANTA, GA)—The American Partnership...

Celebrating APFED’s 15th Anniversary: Q&A...

As APFED begins our 15th year, we caught up with APFED’s founder Beth Allen for...

Are You Up to the...

Elimination Diet Research Study for...

Has your child recently been diagnosed with EoE? Learn more about a new study looking...

Multi-Site Clinical Studies are Enrolling

Longitudinal Study OMEGA: A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and...

APFED to Kick Off 14th...

(Atlanta, GA)—The American Partnership for Eosinophilic Disorders (APFED) is pleased to announce that its 14th...

Get Out and Go! EGIDs...

Summer trips with an EGID can be challenging. We asked for suggestions to ease travel...

National Eosinophil Awareness Week

2016 National Eosinophil Awareness Week is May 15 - 21!   [su_button url="https://apfed.org/toolkit-for-individual-supporters/" target="blank" style="flat"...

Annual Conference July 8-9

APFED’s 14th Annual Patient Education Conference on Eosinophilic Gastrointestinal Disorders Sheraton San Diego Hotel &...

Consortium of EGID Researchers

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is a collaborative effort made possible through...

Life notes: Parents advocating for...

Dawn McCoy never dreamed she’d be using the professional skills she honed as an education...

New NIH-funded Research Network Focuses...

Patient advocacy group offers full support Atlanta, GA. (October 8, 2014) – The American Partnership...

Zach fights back – living...

BOYNTON BEACH, Fla. - Zach Blair is among the most competitive 11 year olds on...